Hepatopulmonary syndromes

Gut

Volumn 46, Issue 1, 2000, Pages 1-4

  Krowka, M J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEPATOPULMONARY SYNDROME; HUMAN; HYDROTHORAX; LUNG ANGIOGRAPHY; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ALPHA 1-ANTITRYPSIN DEFICIENCY; HEPATOPULMONARY SYNDROME; HUMANS; HYDROTHORAX; HYPERTENSION, PULMONARY;

EID: 0034025843     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.1.1     Document Type: Article

References (30)

1. 1 Herve P, Lebrec D, Brenot F, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998;11:1153-66.
2. 2 Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997;25:1282-4.
3. 3 Abrams GA, Nanda NC, Dubovsky EV, et al. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998;114:305-10.
4. 4 Rydell R, Hoffbauer FW. Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. Am J Med 1956;21:450-9.
5. 5 Whyte MKB, Hughes JMB, Peters AM, et al. Analysis of right to left shunt in hepatopulmonary syndrome. J Hepatol 1998;29:85-93.
6. 6 Martinez G, Barbera JA, Navasa M, et al. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol 1999;30:882-9.
7. 7 Krowka MJ, Porayko, MK, Plevak DJ, et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997;72:44-52.
8. 8 Egawa H, Kasahara M, Inomata Y, et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999;67:712-17.
9. 9 Srivasta D, Preminger T, Lock JE, et al. Hepatic venous return and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation 1995;92:1217-22.
10. 10 Duncan BW, Kneebone JM, Chi EY, et al. A detailed histologic analysis of pulmonary arteriovenous malformations in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg 1999;117:931-8.
11. 11 Clement B, Musso O, Lietard J, et al. Homestatic control of angiogenesis: a newly identified function of the liver? Hepatology 1999;29:621-3.
12. 12 Fallon MB, Abrams GA, Luo B, et al. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997;113:606-14.
13. 13 Castro M, Krowka MJ, Schroeder DR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 1996;71:543-51.
14. 14 Edwards BS, Weir EK, Edwards WD, et al. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol 1987;10:1233-8.
15. 15 Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 1991;17:492-8.
16. 16 Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216-23.
17. 17 Kuo PC, Plotkin JS, Johnson LB, et al. Distinctive features of portopulmonary hypertension. Chest 1997;112:980-6.
18. 18 Kuo PC, Johnson LB, Plotkin JS, et al. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997;63:604-6.
19. 19 Plotkin JS, Kuo PC, Rubin LJ, et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 1998;65:457-9.
20. 20 Krowka MJ, Frantz RF, McGoon MD, et al. Improvement in pulmonary hemodynamics with intravenous epoprostenol: a study of 15 patients with portopulmonary hypertension. Hepatology 1999;25:641-8.
21. 21 Findlay JY, Plevak DJ, Krowka MJ, et al. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transplant Surg 1999;5:362-5.
22. 22 Ramsay MAE, Simpson BR, Nguyen AT, et al. Severe pulmonary hypertension in liver transplant candidates. Liver Transplant Surg 1997;3: 494-9.
23. 23 Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 1999;159:1925-32.
24. 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998;53:501-5.
25. 1-antitrypsin. Am J Respir Crit Care Med 1998;158:49-59.
26. 1-antitrypsin. Eur Respir J 1998;11:428-33.
27. 27 Lazardis PP, Kamath PR, Krowka MJ. Hepatic hydrothorax. Am J Med 1999;107:262-7.
28. 28 Agusti AGN, Cardus J, Roca J, et al. Ventilation perfusion mismatch in patients with pleural effusion. Am J Respir Crit Care Med 1997;156:1205-9.
29. 29 Jeffries MA, Kazanjian S, Wilson M, et al. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transplant Surg 1998;4:416-23.
30. 30 Gordon FD, Anastopoulus HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997;25:1366-9.